NOVAN INC (NOVN) Fundamental Analysis & Valuation

NASDAQ:NOVN • US66988N2053

Current stock price

0.0941 USD
-0.03 (-24.84%)
At close:
0.0894 USD
0 (-4.99%)
After Hours:

This NOVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NOVN Profitability Analysis

1.1 Basic Checks

  • NOVN had negative earnings in the past year.
  • In the past year NOVN has reported a negative cash flow from operations.
NOVN Yearly Net Income VS EBIT VS OCF VS FCFNOVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M -50M

1.2 Ratios

  • The profitability ratios for NOVN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOVN Yearly ROA, ROE, ROICNOVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 1K 2K

1.3 Margins

  • With a decent Gross Margin value of 66.06%, NOVN is doing good in the industry, outperforming 73.24% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for NOVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NOVN Yearly Profit, Operating, Gross MarginsNOVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NOVN Health Analysis

2.1 Basic Checks

  • NOVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NOVN has been increased compared to 1 year ago.
  • NOVN has a worse debt/assets ratio than last year.
NOVN Yearly Shares OutstandingNOVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
NOVN Yearly Total Debt VS Total AssetsNOVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • NOVN has an Altman-Z score of -6.93. This is a bad value and indicates that NOVN is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NOVN (-6.93) is worse than 69.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.93
ROIC/WACCN/A
WACC8.45%
NOVN Yearly LT Debt VS Equity VS FCFNOVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M

2.3 Liquidity

  • NOVN has a Current Ratio of 0.74. This is a bad value and indicates that NOVN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOVN has a worse Current ratio (0.74) than 91.08% of its industry peers.
  • NOVN has a Quick Ratio of 0.74. This is a bad value and indicates that NOVN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOVN has a worse Quick ratio (0.72) than 86.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.72
NOVN Yearly Current Assets VS Current LiabilitesNOVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. NOVN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.76% over the past year.
  • NOVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 512.74%.
  • NOVN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.73% yearly.
EPS 1Y (TTM)21.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.94%
Revenue 1Y (TTM)512.74%
Revenue growth 3Y69.07%
Revenue growth 5Y61.73%
Sales Q2Q%64.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.25% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, NOVN will show a very strong growth in Revenue. The Revenue will grow by 62.45% on average per year.
EPS Next Y78.75%
EPS Next 2Y44.82%
EPS Next 3Y29.1%
EPS Next 5Y23.25%
Revenue Next Year19.34%
Revenue Next 2Y95.98%
Revenue Next 3Y75.61%
Revenue Next 5Y62.45%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NOVN Yearly Revenue VS EstimatesNOVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NOVN Yearly EPS VS EstimatesNOVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

4

4. NOVN Valuation Analysis

4.1 Price/Earnings Ratio

  • NOVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 0.58 indicates a rather cheap valuation of NOVN.
  • Based on the Price/Forward Earnings ratio, NOVN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • NOVN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.24.
Industry RankSector Rank
PE N/A
Fwd PE 0.58
NOVN Price Earnings VS Forward Price EarningsNOVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOVN Per share dataNOVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

  • NOVN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOVN's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.82%
EPS Next 3Y29.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NOVN Dividend Analysis

5.1 Amount

  • No dividends for NOVN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVN Fundamentals: All Metrics, Ratios and Statistics

NOVAN INC

NASDAQ:NOVN (7/25/2023, 8:00:02 PM)

After market: 0.0894 0 (-4.99%)

0.0941

-0.03 (-24.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-15
Earnings (Next)08-09
Inst Owners0.1%
Inst Owner Change-98.64%
Ins Owners20.94%
Ins Owner Change0%
Market Cap2.64M
Revenue(TTM)24.92M
Net Income(TTM)-32.05M
Analysts82.86
Price Target15.81 (16701.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.14%
Min EPS beat(2)-65.44%
Max EPS beat(2)71.72%
EPS beat(4)2
Avg EPS beat(4)5.66%
Min EPS beat(4)-65.44%
Max EPS beat(4)71.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.01%
Min Revenue beat(2)-51.38%
Max Revenue beat(2)69.4%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-51.38%
Max Revenue beat(4)69.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)43.52%
PT rev (3m)24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.87%
EPS NY rev (1m)49.28%
EPS NY rev (3m)49.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)-12.59%
Revenue NY rev (3m)-12.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.58
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.51
EYN/A
EPS(NY)0.16
Fwd EY173.43%
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS0.89
BVpS-0.1
TBVpS-1.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.06%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.72
Altman-Z -6.93
F-Score3
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)946.74%
Cap/Depr(5y)585.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.94%
EPS Next Y78.75%
EPS Next 2Y44.82%
EPS Next 3Y29.1%
EPS Next 5Y23.25%
Revenue 1Y (TTM)512.74%
Revenue growth 3Y69.07%
Revenue growth 5Y61.73%
Sales Q2Q%64.21%
Revenue Next Year19.34%
Revenue Next 2Y95.98%
Revenue Next 3Y75.61%
Revenue Next 5Y62.45%
EBIT growth 1Y-10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.42%
OCF growth 3YN/A
OCF growth 5YN/A

NOVAN INC / NOVN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NOVAN INC?

ChartMill assigns a fundamental rating of 2 / 10 to NOVN.


What is the valuation status for NOVN stock?

ChartMill assigns a valuation rating of 4 / 10 to NOVAN INC (NOVN). This can be considered as Fairly Valued.


Can you provide the profitability details for NOVAN INC?

NOVAN INC (NOVN) has a profitability rating of 1 / 10.


What is the earnings growth outlook for NOVAN INC?

The Earnings per Share (EPS) of NOVAN INC (NOVN) is expected to grow by 78.75% in the next year.